Decheng Capital Management Iii (Cayman), LLC 10x Genomics, Inc. Transaction History
Decheng Capital Management Iii (Cayman), LLC
- $181 Million
- Q3 2023
A detailed history of Decheng Capital Management Iii (Cayman), LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Decheng Capital Management Iii (Cayman), LLC holds 359,554 shares of TXG stock, worth $4.79 Million. This represents 8.21% of its overall portfolio holdings.
Number of Shares
359,554
Previous 359,554
-0.0%
Holding current value
$4.79 Million
Previous $20.1 Million
26.13%
% of portfolio
8.21%
Previous 10.64%
Shares
2 transactions
Others Institutions Holding TXG
# of Institutions
290Shares Held
94.7MCall Options Held
263KPut Options Held
85.1K-
Vanguard Group Inc Valley Forge, PA11MShares$146 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.8MShares$143 Million2.31% of portfolio
-
Morgan Stanley New York, NY6.48MShares$86.3 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$85.2 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.37MShares$84.9 Million1.67% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.27B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...